These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
112 related articles for article (PubMed ID: 15289871)
1. Multiple EBNA1-binding sites within oriPI are required for EBNA1-dependent transactivation of the Epstein-Barr virus C promoter. Zetterberg H; Boreström C; Nilsson T; Rymo L Int J Oncol; 2004 Sep; 25(3):693-6. PubMed ID: 15289871 [TBL] [Abstract][Full Text] [Related]
2. Promoter-proximal regulatory elements involved in oriP-EBNA1-independent and -dependent activation of the Epstein-Barr virus C promoter in B-lymphoid cell lines. Nilsson T; Zetterberg H; Wang YC; Rymo L J Virol; 2001 Jul; 75(13):5796-811. PubMed ID: 11390581 [TBL] [Abstract][Full Text] [Related]
3. E2F1, ARID3A/Bright and Oct-2 factors bind to the Epstein-Barr virus C promoter, EBNA1 and oriP, participating in long-distance promoter-enhancer interactions. Boreström C; Forsman A; Rüetschi U; Rymo L J Gen Virol; 2012 May; 93(Pt 5):1065-1075. PubMed ID: 22302879 [TBL] [Abstract][Full Text] [Related]
4. Structural and Functional Basis for an EBNA1 Hexameric Ring in Epstein-Barr Virus Episome Maintenance. Deakyne JS; Malecka KA; Messick TE; Lieberman PM J Virol; 2017 Oct; 91(19):. PubMed ID: 28701406 [TBL] [Abstract][Full Text] [Related]
5. HCF1 and OCT2 Cooperate with EBNA1 To Enhance OriP-Dependent Transcription and Episome Maintenance of Latent Epstein-Barr Virus. Dheekollu J; Wiedmer A; Sentana-Lledo D; Cassel J; Messick T; Lieberman PM J Virol; 2016 Jun; 90(11):5353-5367. PubMed ID: 27009953 [TBL] [Abstract][Full Text] [Related]
6. Epstein-Barr nuclear antigen 1 binds and destabilizes nucleosomes at the viral origin of latent DNA replication. Avolio-Hunter TM; Lewis PN; Frappier L Nucleic Acids Res; 2001 Sep; 29(17):3520-8. PubMed ID: 11522821 [TBL] [Abstract][Full Text] [Related]
7. Ribosome Protein L4 is essential for Epstein-Barr Virus Nuclear Antigen 1 function. Shen CL; Liu CD; You RI; Ching YH; Liang J; Ke L; Chen YL; Chen HC; Hsu HJ; Liou JW; Kieff E; Peng CW Proc Natl Acad Sci U S A; 2016 Feb; 113(8):2229-34. PubMed ID: 26858444 [TBL] [Abstract][Full Text] [Related]
8. Identification of MEF2B, EBF1, and IL6R as Direct Gene Targets of Epstein-Barr Virus (EBV) Nuclear Antigen 1 Critical for EBV-Infected B-Lymphocyte Survival. Tempera I; De Leo A; Kossenkov AV; Cesaroni M; Song H; Dawany N; Showe L; Lu F; Wikramasinghe P; Lieberman PM J Virol; 2016 Jan; 90(1):345-55. PubMed ID: 26468528 [TBL] [Abstract][Full Text] [Related]
9. Functional analyses of the EBNA1 origin DNA binding protein of Epstein-Barr virus. Ceccarelli DF; Frappier L J Virol; 2000 Jun; 74(11):4939-48. PubMed ID: 10799567 [TBL] [Abstract][Full Text] [Related]
10. DNA ligand designed to antagonize EBNA1 represses Epstein-Barr virus-induced immortalization. Yasuda A; Noguchi K; Minoshima M; Kashiwazaki G; Kanda T; Katayama K; Mitsuhashi J; Bando T; Sugiyama H; Sugimoto Y Cancer Sci; 2011 Dec; 102(12):2221-30. PubMed ID: 21910783 [TBL] [Abstract][Full Text] [Related]
11. Nucleophosmin contributes to the transcriptional activation function of the Epstein-Barr virus EBNA1 protein. Malik-Soni N; Frappier L J Virol; 2014 Feb; 88(4):2323-6. PubMed ID: 24284322 [TBL] [Abstract][Full Text] [Related]
12. An imperfect correlation between DNA replication activity of Epstein-Barr virus nuclear antigen 1 (EBNA1) and binding to the nuclear import receptor, Rch1/importin alpha. Kim AL; Maher M; Hayman JB; Ozer J; Zerby D; Yates JL; Lieberman PM Virology; 1997 Dec; 239(2):340-51. PubMed ID: 9434725 [TBL] [Abstract][Full Text] [Related]
13. Functional interaction of nuclear factor y and sp1 is required for activation of the epstein-barr virus C promoter. Boreström C; Zetterberg H; Liff K; Rymo L J Virol; 2003 Jan; 77(2):821-9. PubMed ID: 12502798 [TBL] [Abstract][Full Text] [Related]
14. The 2.2 A structure of a permanganate-sensitive DNA site bound by the Epstein-Barr virus origin binding protein, EBNA1. Bochkarev A; Bochkareva E; Frappier L; Edwards AM J Mol Biol; 1998 Dec; 284(5):1273-8. PubMed ID: 9878348 [TBL] [Abstract][Full Text] [Related]
15. Optimal transactivation by Epstein-Barr nuclear antigen 1 requires the UR1 and ATH1 domains. Singh G; Aras S; Zea AH; Koochekpour S; Aiyar A J Virol; 2009 May; 83(9):4227-35. PubMed ID: 19244333 [TBL] [Abstract][Full Text] [Related]
16. EBNA1. Frappier L Curr Top Microbiol Immunol; 2015; 391():3-34. PubMed ID: 26428370 [TBL] [Abstract][Full Text] [Related]
17. A major EBNA1 variant from Asian EBV isolates shows enhanced transcriptional activity compared to prototype B95.8. Do NV; Ingemar E; Phi PT; Jenny A; Chinh TT; Zeng Y; Hu L Virus Res; 2008 Mar; 132(1-2):15-24. PubMed ID: 18096263 [TBL] [Abstract][Full Text] [Related]
18. Multiple EBNA1-binding sites are required to form an EBNA1-dependent enhancer and to activate a minimal replicative origin within oriP of Epstein-Barr virus. Wysokenski DA; Yates JL J Virol; 1989 Jun; 63(6):2657-66. PubMed ID: 2542579 [TBL] [Abstract][Full Text] [Related]
19. Epstein-Barr virus-positive gastric cancer involves enhancer activation through activating transcription factor 3. Asakawa Y; Okabe A; Fukuyo M; Li W; Ikeda E; Mano Y; Funata S; Namba H; Fujii T; Kita K; Matsusaka K; Kaneda A Cancer Sci; 2020 May; 111(5):1818-1828. PubMed ID: 32119176 [TBL] [Abstract][Full Text] [Related]
20. EBNA1 efficiently assembles on chromatin containing the Epstein-Barr virus latent origin of replication. Avolio-Hunter TM; Frappier L Virology; 2003 Oct; 315(2):398-408. PubMed ID: 14585343 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]